Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01802528

Enrollment

Registered

2013-03-01

Start date

2012-03-31

Completion date

2012-12-31

Last updated

2013-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pelvic Pain

Keywords

obturator externus

Brief summary

Obturator externus (OE) muscle has the possibility as a pain generator, considering its anatomical and functional aspects, but this muscle as a possible target for therapeutic intervention is currently understudied in pain practice.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 75 Years

Healthy volunteers

Inclusion criteria

* 1\. 20-75 adults/ 2. Chronic pelvic pain patients who required the interventional procedures/ 3. patients with a localized tenderness on inferolateral side of the pubic tubercle

Exclusion criteria

* 1\. Severe cardiovascular disease /2. Coagulation abnormality /3. Patient denial

Design outcomes

Primary

Measure	Time frame	Description
Post-injection pain score	at 2 weeks after injection	Before and after the OE muscle injection, patients were asked to rate their pain score using a 10-point numeric rating scale (NRS; 0=no pain, 10=worst possible pain). We also assessed the degree of patient satisfaction as excellent, good, fair, and bad during 2 weeks after injection. In this period, any analgesic medications did not change in all patients. Complications associated with OE muscle injection were investigated.

Countries

South Korea

Outcome results